Proton Pump Inhibitor

As per available reports about 30 journals, 15 Conferences, 15 workshops are presently dedicated exclusively to Proton Pump Inhibitor and about 500,000 articles are being published on the current trends in Proton Pump Inhibitor. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to Proton Pump Inhibitor are being carried out. Proton-pump inhibitors (PPIs) are a group of drugs whose main action is a pronounced and long-lasting reduction of gastric acid production. Proton-pump inhibitors are the strongest type of medicine available for treating stomach acid. Proton pump inhibitors act by irreversibly blocking the hydrogen/potassium adenosine triphosphatase enzyme system of the gastric parietal cells. The proton pump is the terminal stage in gastric acid secretion, being directly responsible for secreting H⁺ ions into the gastric lumen, making it an ideal target for inhibiting acid secretion.

The Journal of Proteomics & Bioinformatics is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals in proteomics. Each year research scientists have noticed a rise in the number of congresses being held in this field. The Journal of Proteomics & Bioinformatics provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of proteomics and bioinformatics, thus bridging the gap between researchers and young scientists.

OMICS International – a pioneer in organizing international conferences. Proteomics Studies give the broad info on Proteomics & Genomics like how genes and proteins are originated and their structure, along with Gene expression. While going into deep studies many investigators still view Genome Annotation as a notoriously unreliable and inaccurate process.